Adhesion of physicians to the national malaria policy: Situation in Antananarivo (Madagascar), 5 years after the policy revision;Adhésion des médecins à la politique nationale de lutte contre le paludisme cinq ans après sa révision: Situation à antananarivo (madagascar)

Medecine et sante tropicales

Volumn 22, Issue 2, 2012, Pages 177-181

  Andrianasolo, R L ^a   Rakotoson, J ^b   Rakotoarivelo, R A ^a   Andriamahenina, R ^c   Mamy Randria, J D ^a   Rabenja Rapelanoro, F ^d  

^a Service des Maladies Infectieuses   (France)

^b Service de Pneumologie   (France)

^c Service statistique   (France)

^d CHU d'Antananarivo   (Madagascar)

Author keywords

Adherence; Madagascar; Malaria; National policy; Physicians

Indexed keywords

EID: 84869055685     PISSN: 22613684     EISSN: 22612211     Source Type: Journal    
DOI: 10.1684/mst.2012.0051     Document Type: Article

References (26)

1. Andriantsoanirina V, Menard D, Tuseo L, Durand R. History and current status of Plasmodium falciparum antimalarial drug resistance in Madagascar. Scand J Infect Dis 2010; 42: 22-32.
2. Bencimon C, Belmonte O, Randrianarivelojosia M, Grosjean P, Pfister P, Combe P. Diagnostic du paludisme dans la ville d'Antananarivo: réflexion à partir des résultats obtenus à l'Institut Pasteur de Madagascar de 2001 à 2004. Bull Soc Pathol Exot 2006; 99: 198-199.
3. Randrianarivelojosia M, Raveloson A, Randriamanantena A, et al. Lessons learnt from the six decades of chloroquine use (1945-2005) to control malaria in Madagascar. Trans R Soc Trop Med Hyg 2009; 103: 3-10.
4. Raharimalala L, Rabarison P, Lepers-Rason MD, et al. Chimiorésistance et stratégie thérapeutique. Sante 1995; 5: 389-392.
5. Randrianarivelojosia M, Fidock DA, Belmonte O, Valderramos SG, Mercereau-Puijalon O, Ariey F. First evidence of pfcrt mutant Plasmodium falciparum in Madagascar. Trans R Soc Trop Med Hyg 2006; 100: 826-830.
6. Attaran A, Barnes KI, Curtis C, et al. WHO, the Global Fund, and medical malpractice in malaria treatment. Lancet 2004; 363: 237-240.
7. WHO. Access to antimalarial medicine: improving the affordability and financing of artemisinin-based combination therapies. WHO ed, Geneva, 2003, p. 32.
8. Amin AA, Zurovac D, Kangwana BB, et al. The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya. Malar J 2007; 6: 72.
9. Malenga G, Wirima J, Kazembe P, et al. Developing national treatment policy for falciparum malaria in Africa: Malawi experience. Trans R Soc Trop Med Hyg 2009; 103: S15-S18.
10. Whitty CJ, Chandler C, Ansah E, Leslie T, Staedke SG. Deployment of ACT antimalarials for treatment of malaria: challenges and opportunities. Malar J 2008; 7: S7.
11. Rakotoarivelo R, Raveloson H, Andrianasolo R, Razafimahefa S, Randria M. Aspects cliniques et thérapeutiques du paludisme grave de l'adulte en milieu hospitalier à Antananarivo, Madagascar. Bull Soc Pathol Exot 2009; 102: 215-216.
12. Juma E, Zurovac D. Changes in health workers' malaria diagnosis and treatment practices in Kenya. Malar J 2011; 10: 1.
13. Mubyazi G, Gonzalez-Block M. Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug. Malar J 2005; 4: 51.
14. Williams HA, Vincent-Mark A, Herrera Y, Chang OJ. A retrospective analysis of the change in anti-malarial treatment policy: Peru. Malar J 2009; 8: 85.
15. Zurovac D, Njogu J, Akhwale W, Hamer DH, Larson BA, Snow RW. Effects of revised diagnostic recommendations on malaria treatment practices across age groups in Kenya. Trop Med Int Health 2008; 13: 784-787.
16. Zurovac D, Midia B, Ochola SA, English M, Snow RW. Microscopy and outpatient malaria case management among older children and adults in Kenya. Trop Med Int Health 2006; 11: 432-440.
17. Reyburn H, Mbakilwa H, Mwangi R, et al. Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial. Bmj 2007; 334: 403.
18. Bisoffi Z, Sirima BS, Angheben A, et al. Rapid malaria diagnostic tests vs. clinical management of malaria in rural Burkina Faso: safety and effect on clinical decisions. A randomized trial. Trop Med Int Health 2009; 14: 491-498.
19. Zurovac D, Njogu J, Akhwale W, Hamer DH, Snow RW. Translation of artemether-lumefantrine treatment policy into paediatric clinical practice: an early experience from Kenya. Trop Med Int Health 2008; 13: 99-107.
20. Zurovac D, Ndhlovu M, Sipilanyambe N, et al. Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat crosssectional study. Malar J 2007; 6: 31.
21. Lemma H, Byass P, Desta A, et al. Deploying artemether-lumefantrine with rapid testing in Ethiopian communities: impact on malaria morbidity, mortality and healthcare resources. Trop Med Int Health 2010; 15: 241-250.
22. Hamer DH, Ndhlovu M, Zurovac D, et al. Improved diagnostic testing and malaria treatment practices in Zambia. Jama 2007; 297: 2227-2231.
23. Wasunna B, Zurovac D, Goodman CA, Snow RW. Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine. Malar J 2008; 7: 29.
24. Williams HA, Durrheim D, Shretta R. The process of changing national malaria treatment policy: lessons from country-level studies. Health Policy Plan 2004; 19: 356-370.
25. Breman JG, Alilio MS, Mills A. Conquering the intolerable burden of malaria: what's new, what's needed: a summary. Am J Trop Med Hyg 2004; 71: 1-15.
26. Zurovac D, Tibenderana JK, Nankabirwa J, et al. Malaria casemanagement under artemether-lumefantrine treatment policy in Uganda. Malar J 2008; 7: 181.